Brian John Andr Gill MD (He/Him)
Brain & Spinal Tumor
Assistant Professor of Neurological Surgery
710 West 168th StreetNew York, NY 10032
Overview of Dr. Gill
Dr. Brian Gill is a neurosurgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 12 years. He is one of 146 doctors at New York-Presbyterian Hospital and one of 53 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurosurgery. He has more than 30 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Neurosurgical Oncology, 2021 - 2022
New York Presbyterian Hospital (Columbia Campus)Residency, Neurological Surgery, 2014 - 2021
Columbia University Vagelos College of Physicians and SurgeonsClass of 2014
Certifications & Licensure
NY State Medical License 2021 - 2028
NJ State Medical License 2022 - 2027
CT State Medical License 2022 - 2026
CO State Medical License 2022 - 2023
Clinical Trials
- A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma Start of enrollment: 2023 Mar 20
Roles: Principal Investigator, Contact
- Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM Start of enrollment: 2024 Jan 29
Publications & Presentations
PubMed
- 1 citationsThree-dimensional visualization of arrhythmogenic substrate in mouse hearts using panoramic optical mapping and micro-computed tomography.Lea Melki, Uma Mahesh R Avula, Pavithran Guttipatti, Ruiping Ji, Najla Saadallah
Nature Cardiovascular Research. 2026-05-01 - Electrophysiologically Targeted Biopsies Reveal the Transcriptional Landscape of Focal Epilepsy.Ashwin Viswanathan, Molly Murch, Abby Brand, Julia L Furnari, Nathaniel W Rolfe
Biorxiv. 2026-03-10 - IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosis.Angeliki Mela, Abby Brand, Aayushi Mahajan, Athanassios Dovas, Nelson Humala
Biorxiv. 2026-02-02
Grant Support
- The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in GliomaCOLUMBIA UNIVERSITY HEALTH SCIENCES2025–2030
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
